BioMers
Midview City
About BioMers
BioMers is a medical device company that specializes in the development of novel polymer composite technology for biomedical applications. Through its patented technological breakthrough, BioMers introduced SimpliClear, the world only completely clear orthodontic solution that can be used to treat a wide range of teeth irregularities, from mild to complex patient cases. With SimpliClear, patients can undergo orthodontic treatment without the embarrassment of unsightly metal braces. The product has been approved by US, Canada, Australia, Malaysia, Singapore, EU...regulators. The orthodontic industry has sought the development of an esthetic alternative to metal braces for over 30 years. However, past solutions have limited applicability to a wide range of cases. BioMers solved the problem through the development of a clinically proven clear orthodontic wire, the backbone of tooth movement. Founded as a spin-off from the National University of Singapore (NUS), BioMers is a Singapore-based company with a wholly-own subsidiary in China.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $6.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Feb 2018)
- Website: simpliclear.com
- Phone: +65-6779-5909
Industries & Categories
Beauty, Dental, Fitness, Health Care, Wellness
Social Profiles
Canonical: https://fsome.com/organization/biomers-166453 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.